Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 85.2x - 94.1x | 89.7x |
| Selected Fwd Revenue Multiple | 58.0x - 64.1x | 61.0x |
| Fair Value | €0.45 - €0.49 | €0.47 |
| Upside | -46.3% - -40.8% | -43.5% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| DIAGNOS Inc. | ADK | TSXV:ADK |
| nDatalyze Corp. | NDAT | CNSX:NDAT |
| KDA Group Inc. | KDA | TSXV:KDA |
| CardioComm Solutions, Inc. | EKG | TSXV:EKG |
| Vitalhub Corp. | VHI | TSX:VHI |
| NetraMark Holdings Inc. | PF0 | DB:PF0 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| ADK | NDAT | KDA | EKG | VHI | PF0 | |||
| TSXV:ADK | CNSX:NDAT | TSXV:KDA | TSXV:EKG | TSX:VHI | DB:PF0 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | -20.7% | -8.5% | -63.6% | -9.7% | 46.3% | NM- | ||
| 3Y CAGR | -38.2% | -47.4% | -81.8% | -8.3% | 40.6% | NM- | ||
| Latest Twelve Months | -39.0% | -92.7% | 93.4% | -30.3% | 36.0% | 179.4% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | -1117.8% | -532.2% | -1631.9% | -24.7% | 7.0% | -5354.4% | ||
| Prior Fiscal Year | -1532.3% | -549.9% | -2053.8% | -16.0% | 13.1% | -6686.5% | ||
| Latest Fiscal Year | -3684.2% | -74.1% | -3236.6% | -43.5% | 14.2% | -761.1% | ||
| Latest Twelve Months | -3684.2% | -5247.6% | -3059.2% | -44.7% | 12.5% | -658.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 214.32x | 3.27x | 223.87x | 4.41x | 6.31x | 123.17x | ||
| EV / LTM EBIT | -5.8x | -0.1x | -7.3x | -9.9x | 50.5x | -32.3x | ||
| Price / LTM Sales | 215.90x | 67.39x | 229.25x | 3.79x | 7.52x | 125.67x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 3.27x | 6.31x | 223.87x | |||||
| Historical EV / LTM Revenue | 90.57x | 116.70x | 199.29x | |||||
| Selected EV / LTM Revenue | 85.17x | 89.65x | 94.13x | |||||
| (x) LTM Revenue | 1 | 1 | 1 | |||||
| (=) Implied Enterprise Value | 53 | 56 | 58 | |||||
| (-) Non-shareholder Claims * | 2 | 2 | 2 | |||||
| (=) Equity Value | 55 | 58 | 61 | |||||
| (/) Shares Outstanding | 92.1 | 92.1 | 92.1 | |||||
| Implied Value Range | 0.60 | 0.63 | 0.66 | |||||
| FX Rate: CAD/EUR | 1.6 | 1.6 | 1.6 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.38 | 0.40 | 0.42 | 0.84 | ||||
| Upside / (Downside) | -54.1% | -51.8% | -49.5% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | ADK | NDAT | KDA | EKG | VHI | PF0 | |
| Enterprise Value | 22 | 0 | 48 | 2 | 474 | 118 | |
| (+) Cash & Short Term Investments | 3 | 1 | 1 | 0 | 91 | 2 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (3) | 0 | (1) | (0) | (1) | 0 | |
| (-) Other Liabilities | 0 | 0 | 1 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 22 | 1 | 49 | 2 | 564 | 120 | |
| (/) Shares Outstanding | 101.9 | 41.3 | 193.5 | 193.1 | 55.8 | 92.1 | |
| Implied Stock Price | 0.22 | 0.02 | 0.26 | 0.01 | 10.11 | 1.30 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.56 | |
| Implied Stock Price (Trading Cur) | 0.22 | 0.02 | 0.26 | 0.01 | 10.11 | 0.84 | |
| Trading Currency | CAD | CAD | CAD | CAD | CAD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.56 | |